Noninvasive assessment of characteristics of novel anti-HER2
Descrição
IJMS, Free Full-Text
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model
Tumor-Targeting Ability of Novel Anti-Prostate-Specific Membrane Antigen Antibodies
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer - ScienceDirect
Summary of bioinformatics analysis that were used for HER2 peptide
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials
Frontiers Pre-Clinical Study of the [18F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics
Frontiers Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer
Cancers, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
